The fatty acid side chain used in CY-5 is same as that of semaglutide, used in tirzepatide just having two more carbon as C20, used in MAR709 is a simple C16 chain without spacer located at Lys 40 .6,15,16 Taken together, the appropriate length is between C16 and C20 and most suitable lipidation position can be chosen from the following range of positions (starting from position 1): 10, 16, 20, 21, 28, and C-terminal.2,48 Apart from fatty acid chains, there are other molecules that could be used to connect to albumin and could be worth exploring.49 The semaglutide development process shows that the lipidation approach is decisive to the selectivity of the protein
Most studies have demonstrated decreased intestinal microbiota diversity in patients with IBD (Willing et al., 2010
"Getting Prior Authorizations for TRICARE Prescriptions: Your Questions Answered." tricare.mil TRICARE
Pharmacological profiles of peptide drug candidates for the treatment of Alzheimers disease